SPRO

Shukla Sath

Known title: Chief Financial OfficerCIK: 0001782817

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

SPRO among stocks that gapped in Tuesday's session. Spero Therapeutics was listed as a gapping stock on Tuesday, meaning its price opened significantly different from the previous close. Such gaps often reflect a quick shift in market sentiment. The move occurs while the stock is near its $1.19 support level and has a neutral RSI around 49.

this person other insiders at SPRO

Transaction History

SPRO▼ Sell$5K
SPRO▼ Sell$33K
SPRO▼ Sell$83K
SPRO▲ Buy$0
SPRO▼ Sell$4K
SPRO▼ Sell$23K
SPRO▼ Sell$20K
SPRO▼ Sell$65K
SPRO▼ Sell$42K
SPRO▲ Buy$0
SPRO▼ Sell$5K
SPRO▼ Sell$2K
SPRO▲ Buy$0
SPRO▼ Sell$17K
SPRO▲ Buy$0
SPRO▼ Sell$5K
SPRO▲ Buy$0
SPRO▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.